Clinical Trials

GastrointestinalGenitourinarySarcoma

14 enrolled 12 charts

Liposarcoma, Liver Neoplasms, Wilms Tumor, Rhabdomyosarcoma, Endodermal Sinus Tumor, Rhabdoid Tumor

NCT00582647 2026-01-15

Collection of Tissue & Blood From Patients w/ Benign & Malignant Tumors of the Soft Tissue & Gastrointestinal Tract

DermatologicGastrointestinalSarcoma

6,000 enrolled

Bile Duct Neoplasms, Esophageal Neoplasms, Liver Neoplasms, Melanoma, Pancreatic Neoplasms, Sarcoma, Stomach Neoplasms

NCT01494324 2026-01-02

Examinations of Tissue From Ablated Malignant Liver Metastases as Predictors of Outcome

150 enrolled

Liver Neoplasms

NCT04658147 2025-12-18

Feasibility and Efficacy of Perioperative Nivolumab With or Without Relatlimab for Patients With Potentially Resectable Hepatocellular Carcinoma (HCC)

31 enrolled

Carcinoma, Hepatocellular, Liver Neoplasms

NCT03623464 2025-12-17

RCT of Mobile Apps & FitBit v. Usual Care

107 enrolled

Colonic Neoplasms, Liver Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms

NCT02869217 2025-12-03

Study of TBI-1301 (NY-ESO-1 Specific TCR Gene Transduced Autologous T Lymphocytes) in Patients With Solid Tumors

DermatologicGastrointestinalGenitourinaryGynecologicSarcomaThoracic

22 enrolled

Urinary Bladder Neoplasms, Esophageal Neoplasms, Liver Neoplasms, Lung Neoplasms, Melanoma, Ovarian Neoplasms, Sarcoma, Synovial

NCT06141564 2025-11-18

DTECT-Liver

360 enrolled

Liver Neoplasms

NCT07233759 2025-11-18

The Study Collect Clinical Data From the Treatment of Liver Cancer With New Drugs After 2019 and Integrate Biochemical and Pathological Indicators to Analyze Prognostic Outcomes, Including Overall Survival, Progression-free Survival, and Complications.

2,500 enrolled

Liver Neoplasms

NCT07214363 2025-10-09

The Safety and Efficacy of Irreversible Electroporation for the Treatment of Perivascular Liver Cancers

20 enrolled

Liver Neoplasms

NCT07207343 2025-10-03

Symptomatic Abdominal Tumors Are Unsuitable for Surgical Resection, High-intensity Focused Ultrasound (HIFU) Treatment Will be Applied to the Tumors. Postoperatively, Continuous Evaluation and Analysis of the Ablation Effect Will be Performed Using CT or MRI Imaging.

38 enrolled

Liver Neoplasms

NCT02932956 2025-09-19

GAP

10 enrolled

Phase 1/2 Active not recruiting

Liver Neoplasms

NCT07034950 2025-09-11

Effective Dose and Safety of Esketamine During Ultrasound-guided Hepatic Tumor Thermal Ablation

79 enrolled

Liver Neoplasms, Pain

NCT06384417 2025-08-08

Using an End-of-life Conversation Game to Engage Patients With Cancer in Advance Care Planning: Phase 2

BreastDermatologicGastrointestinalHead & NeckThoracic

32 enrolled

Breast Neoplasms, Head and Neck Neoplasms, Liver Neoplasms, Lung Neoplasms, Melanoma, Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Urogenital Neoplasms, Colorectal Neoplasms

NCT03651154 2025-07-31

PRICE2

440 enrolled

Liver Neoplasms, Blood Loss, Surgical

NCT04186234 2025-07-29

SBRT for Liver Cancer Before Liver Transplantation

71 enrolled

Phase 3 Active not recruiting

Liver Neoplasms

NCT02523443 2025-07-22

Patient Controlled Epidural Analgesia Versus Intravenous Patient Controlled Analgesia for Post-Operative Pain Control in Patients Undergoing Elective Liver Resection

231 enrolled

Phase 2 Active not recruiting

Agnosia, Liver Neoplasms

NCT05724563 2025-05-21

Domvanalimab and Zimberelimab in Advanced Liver Cancers

58 enrolled

Carcinoma, Hepatocellular, Liver Neoplasms, Cholangiocarcinoma

NCT06966986 2025-05-13

Radiofrequency-responsive Layered Double Hydroxides for Enhanced Arterial Embolization and Thermal Immunotherapy in Hepatocellular Carcinoma

130 enrolled

Phase EARLY_PHASE1 Active not recruiting

Carcinoma, Hepatocellular, Liver Neoplasms

NCT03143270 2025-05-02

A Study to Test the Safety and Feasibility of Nivolumab With Drug Eluting Bead Transarterial Chemoembolization in Patients With Liver Cancer

20 enrolled

Phase 1/2 Active not recruiting

Liver Neoplasms

NCT05964361 2025-04-25

IL15-TransDC

10 enrolled

GastrointestinalGynecologic

Esophageal Neoplasms, Liver Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms

NCT04196465 2025-04-10

NeoChance

Phase 2 Active not recruiting

48 enrolled

Liver Neoplasms

NCT02908048 2025-04-06

Extracellular RNA Markers of Liver Disease and Cancer

1,810 enrolled

Bile Duct Neoplasms, Biliary Tract Neoplasms, Fibrosis, Hepatitis, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Cholangiocarcinoma

NCT02984566 2025-04-04

TROG1703 LARK

32 enrolled

Carcinoma, Hepatocellular, Liver Neoplasms

NCT06707025 2025-03-14

CD24CCA

50 enrolled

Liver Neoplasms, Cholangiocarcinoma

NCT06703853 2024-11-25

cfDNA

1,000 enrolled

Liver Neoplasms, Neoplasms

NCT05931445 2024-04-23

Patient Reported Outcomes Study Using Electronic Monitoring System for Advanced or Metastatic Solid Cancer

BreastGastrointestinalGynecologicHead & NeckThoracic

500 enrolled

Squamous Cell Carcinoma of Head and Neck, Breast Neoplasms, Liver Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT06315361 2024-03-18

DIANA

600 enrolled

Diabetes Mellitus, Fibrosis, Liver Cirrhosis, Liver Neoplasms, Non-alcoholic Fatty Liver Disease

NCT04242342 2024-02-12

RASTAF

46 enrolled

Liver Neoplasms

NCT03347162 2023-06-22

Muscle Dysfunction in Gastrointestinal or Hepatobiliary Cancer

1,000 enrolled